Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.

about

Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q47225007

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Impact of surgical treatment a ...... nced hepatocellular carcinoma.

@en

Impact of surgical treatment a ...... nced hepatocellular carcinoma.

@nl

type

Item

label

Impact of surgical treatment a ...... nced hepatocellular carcinoma.

@en

Impact of surgical treatment a ...... nced hepatocellular carcinoma.

@nl

prefLabel

Impact of surgical treatment a ...... nced hepatocellular carcinoma.

@en

Impact of surgical treatment a ...... nced hepatocellular carcinoma.

@nl

P1476

Impact of surgical treatment a ...... nced hepatocellular carcinoma.

@en

P2093

Akira Chikamoto

http://www.w3.org/2001/XMLSchema#string

Daisuke Hashimoto

http://www.w3.org/2001/XMLSchema#string

Hideaki Takeyama

http://www.w3.org/2001/XMLSchema#string

Hideo Baba

http://www.w3.org/2001/XMLSchema#string

Hidetoshi Nitta

http://www.w3.org/2001/XMLSchema#string

Hirohisa Okabe

http://www.w3.org/2001/XMLSchema#string

Hiromitsu Hayashi

http://www.w3.org/2001/XMLSchema#string

Katsunobu Taki

http://www.w3.org/2001/XMLSchema#string

Katsunori Imai

http://www.w3.org/2001/XMLSchema#string

Kota Arima

http://www.w3.org/2001/XMLSchema#string

P2860

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer.

Recurrence-free survival of a hepatocellular carcinoma patient with tumor thrombosis of the inferior vena cava after treatment with sorafenib and hepatic resection.

Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma.

Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.

Clinical guidance on the perioperative use of targeted agents in solid tumor oncology.

Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update.

Transarterial chemoembolization: modalities, indication, and patient selection.

P31

scholarly article

P356

10.1007/S00595-017-1603-X

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29110089

http://www.w3.org/2001/XMLSchema#string